References
- Anderson, R. L. and W. J. Wolf. 1995. Compositional changes in trypsin inhibitors, phytic acid, saponins and isoflavones related to soybean processing. J. Nutr. 125: 581S-588S.
- Ariyo, A. A. and A. C. Villablanca. 2002. Estrogens and lipids. Can HRT designer estrogens, and phytoestrogens reduce cardiovascular risk markers after menopause? Postgrad Med. 111(1):23-30.
- Barnes, S. 1998. Evolution of the health benefits of soy isoflavones. Proc. Soc. Exp. Biol. Med. 271(3):386-392.
- Berhow, M. A. E. D. Wagner, S. F. Vaughn, and M. J. Plewa. 2000. Characterization and antimutagenic activity of soybean saponins. Mutation Research. 448:11-22. https://doi.org/10.1016/S0027-5107(99)00225-0
- Berhow, M. A., S. B. Kong, K. E. Vermillion, and S. M. Duval. 2006. Complete quantification of group A and group B soyasaponins in soybeans. J. Agric. Food Chem. 54:2035-2044. https://doi.org/10.1021/jf053072o
- Choi, Y. B. and H. S. Sohn. 1997. Recovery of isoflavones from soybean cooking water produced during soymilk manufacturing process. Korean J. Food Sci. Technol., 29: 522-526.
- Clarkson, T. B. 2002. Soy, soy phytoestrogens and cardiovascular disease. J. Nutr. 132:566S-569S.
- Decroos, K., J. P. Vincken, L. Heng, R. Bakker, H. Gruppen, and W. Verstraete. 2005. Simultaneous quantification of differently glycosylated, acetylated, and 2,3-dihydro-2, 5-dihydroxy-6-methyl-4H-pyran-4-one-conjugated soyasaponins using reversed-phase high-performance liquid chromatography with evaporative light scattering detection. J. Chromatogr. A. 1072:185-193. https://doi.org/10.1016/j.chroma.2005.03.021
- Diane F. B., H. Suzanne, and W. Wang. 2001. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacology & Therapeutics. 90:157-177. https://doi.org/10.1016/S0163-7258(01)00137-1
- Hayashi, K, H. Hayashi, N. Hiraoka, and Y. Ikeshiro. 1997. Inhibitory activity of soyasaponin II on virus replication in vitro. Planta Medica, 63, 102-105. https://doi.org/10.1055/s-2006-957622
- Hu, J.; S. O. Lee, S. Hendrich, and P. A. Murphy. 2002. Quantification of the group B soyasaponins by highperformance liquid chromatography. J. Agric. Food Chem. 50:2587-2594. https://doi.org/10.1021/jf0114740
- Iwamura J. and Kashiwara. 1984. Process for isolating saponins and flavonoids from leguminous plants. United State Patent. 4,428,876 (Jan. 31).
- Kinjo, J., M. Imagire, M. Udayama, T. Arao, and T. Nohara. 1988. Structure-hepatoprotective relationships study of soyasaponins I-IV having soyasapogenol B as aglycone. Planta Med. 64:233-236.
- Kitagawa I., H. K. Wang, T. Taniyama, and M. Yoshikawa. 1988a. Saponin and sapogenol. XLI. Reinvestigation of the structures of soyasapogenols A, B, and E, oleanenesapogenols from soybean. Structures of soyasaponins I, II, and III. Chem. Pharm. Bull. 36: 153-161. https://doi.org/10.1248/cpb.36.153
- Kitagawa I., T. Taniyama, Y. Nagahama, K. Okubo, F. Yamauchi, and M. Yoshikawa. 1988b. Saponin and sapogenol. XLII. Structures of acetyl-soyasaponins A1, A2, and A3, astringent partially acetylated bisdesmosides of soyasapogenol A, from American soybean, the seeds of Glycine max Merrill. Chem. Pharm. Bull. 36:2819-2828. https://doi.org/10.1248/cpb.36.2819
- Konoshima, T., M. Kokumai, M. Kozuka, H. Tokuda, H. Nishino, and A. Iwashima. 1992. Anti-tumor-promoting activities of afromosin and soyasaponin I isolated from Wistaria brachybotrys. J Nat Prod 55:1776-1778. https://doi.org/10.1021/np50090a011
- Koratkar, R. and A. V. Rao. 1997. Effect of soya bean saponins on azoxymethane-induced preneoplastic lesions in the colon of mice. Nutr. Cancer. 27:206-209. https://doi.org/10.1080/01635589709514526
- Kudou, S., M. Tonomura, C. Tsukamoto, M. Shimoyamada, T. Uchida, and K. Okubo. Isolation and structural elucidation of the major genuine soybean saponin. Biosci. Biotechnol. Biochem. 1992, 56:142-143. https://doi.org/10.1271/bbb.56.142
- Lichtenstein, A. H. 2001. Got Soy ? (Editorial). Am. J. Clin. Nutr. 73(4):667-668.
- Liu, K. S. 1997. Soybeans: Chemistry, tchnology and uilization, Springer. p. 4-5.
- Shibuya M., K. Nishimura, N. Yasuyama, and Y. Ebizuka. 2010. Identification and characterization of glycosyltransferases involved in the biosynthesis of soyasaponin I in Glycine max. FEBS Letters. 584:2258-2264. https://doi.org/10.1016/j.febslet.2010.03.037
- Messina M. J., V. Persky, K. D. Setchell, and S. Barnes. 1994. Soya intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer. 21:113-131. https://doi.org/10.1080/01635589409514310
- Miksicek, R. J. 1994. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J. Steroid Biochem. Mol. Biol. 49(2-3): 153-160. https://doi.org/10.1016/0960-0760(94)90005-1
- Miyao, H., T. Arao, M. Udayama, J. Kinjo, and T. Nohara. 1998. Kaikasaponin III and soyasaponin I, major triterpenesaponins of Abruscantoniensis, act on GOT and GPT; influence on transaminase elevation of rat liver cells concomitantly exposed to CCl4 for one hour. Planta Med. 64:5-7. https://doi.org/10.1055/s-2006-957355
- Rao, A. V. and M. K. Sung. 1995. Saponins as anticarcinogens. J. Nutr. 125:717S-724S.
-
Sanders, T. A. B., S. D. Tracey, G. David, J. M. George, and W. Helen. 2002. Moderate intakes of intact soy protein rich in isoflavones compared with ethanol-extracted soy protein increase HDL but do not influence transforming growth factor
${\beta}1$ concentrations and hemostatic risk factors for coronary heart disease in healthy subjects. Am. J. Clin. Nutr. 76(2):373-377. - Sarkar, F. H. and Y. Li. 2003. Soy isoflavones and cancer prevention. Cancer Invest. 21:817-818. https://doi.org/10.1081/CNV-120023782
- Scheiber M. D., J. H. Liu, M. T. Subbiah, R. W. Rebar, and K. D. Setchell. 2001. Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women. Menopause. 8(5):384-392. https://doi.org/10.1097/00042192-200109000-00015
- Setchell K. D., N. M. Brown, and E. Lydeking-Olsen. 2002. The clinical importance of the metabolite equol-A clue to the effectiveness of soy and its isoflavones. J. Nutr. 132(12):3577-3584.
- Setchell, K. D. and A. Cassidy. 1999. Dietary isoflavones: biological effects and relevance to human health. J. Nutr. 129:758S-767S.
- Shiraiwa, M., S. Kudou, M. Shimoyamada, K. Harada, and K. Okubo, 1991. Composition and structure of "group A saponin" in soybean seed. Agric. Biol. Chem. 55:315-322 & 55:911-917. https://doi.org/10.1271/bbb1961.55.315
- Sirtor, C. R. 2001. Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis. Drug Saf. 24(9):665-682. https://doi.org/10.2165/00002018-200124090-00003
- Taniyama T., Y. Nagahama, M. Yoshikawa, and I. Kitagawa. 1988. Saponin and sapogenol. XLIII. acetyl-soyasaponins A4, A5, and A6, new astringent bisdesmosides of soyasapogenol A, from Japanese soybean, the seeds of Glycine max Merrill. Chem. Pharm. Bull. 36:2829-2839. https://doi.org/10.1248/cpb.36.2829
- Tham, D. M., C. D. Gardner, and W. L. Haskell. 1998. Clinical review 97: Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J. Clin. Endocrinol. Metab. 83(7):2223-2235. https://doi.org/10.1210/jc.83.7.2223
- Tikkanen, M. J. and H. Adlercreutz. 2000. Dietary soyderived isoflavone phytoestrogens. Could they have a role in coronary heart disease prevention? Biochem. Pharmacol. 60(1):1-5. https://doi.org/10.1016/S0006-2952(99)00409-8
- Tsukamoto, C., A. Kikuchi, K. Harada, K. Kitamura, and K. Okubo. 1993. Genetic and chemical polymorphisms of saponins in soybean seed. Phytochemistry. 34(5):1351-1356. https://doi.org/10.1016/0031-9422(91)80028-Y
- Vlietinck, A. J., T. De Bruyne, S. Apers, and L. A. Pieters. 1998. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection. Planta Med. 64:97-109. https://doi.org/10.1055/s-2006-957384
- Wang, H., and P. Murphy. 1994. Isoflavone composition of American and Japanese soybeans in Iowa: Eff ects of variety, crop year and location. J. Agric. Food Chem. 42: 1674-1677. https://doi.org/10.1021/jf00044a017
-
Yoshiki Y., S. Takagi, M. Watanabe, and K. Okubo, 2005. Fractionation of soybean functional glycosides from soywaste based on the chemical reaction of soyasaponin
$\beta$ g. Food Chemistry. 93:591-597. https://doi.org/10.1016/j.foodchem.2004.10.042 - Yoshiki, Y. M. Kinumi, T. Kahara, and K. Okubo. 1996. Chemiluminescence of soybean saponins in the presence of active oxygen species. Plant Science. 116:125-129. https://doi.org/10.1016/0168-9452(96)04375-0
- Yoshikoshi, M., Y. Yoshiki, K. Okubo, J. Seto, and Y. Sasaki. 1996. Prevention of hydrogen peroxide damage by soybean saponins to mouse fibroblasts. Planta Med. 62: 252-255. https://doi.org/10.1055/s-2006-957871
Cited by
- Hepatoprotective Effects of Soybean Embryo by Enhancing Adiponectin-Mediated AMP-Activated Protein KinaseαPathway in High-Fat and High-Cholesterol Diet-Induced Nonalcoholic Fatty Liver Disease vol.19, pp.6, 2016, https://doi.org/10.1089/jmf.2015.3604